Other products from "WILTROM CO., LTD."
No Primary DI Version or Model Catalog Number Device Description Product Code Product Code Name Device Class Brand Name
1 04719873024223 43555035 Polyaxial Pedicle Screw ø=5.0 / L=35 The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link conn The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link connector and associated surgical instruments thatallow the surgeon to build an implant system to fit the patient's anatomical and physiological requirements. The Wiltrom SpinalFixation System is designed to be used to stabilize the vertebrae through a posterior approach. The Wiltrom spinal implants aremade of Ti-6Al-4V ELI material which complies with ISO 5832-3 and ASTM F136. Wiltrom Spinal Fixation System is provided nonsterile,and the implants are for single use only. NKB Thoracolumbosacral Pedicle Screw System 2 WILTROM SPINAL FIXATION SYSTEM
2 04719873024216 43555030 Polyaxial Pedicle Screw ø=5.0 / L=30 The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link conn The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link connector and associated surgical instruments thatallow the surgeon to build an implant system to fit the patient's anatomical and physiological requirements. The Wiltrom SpinalFixation System is designed to be used to stabilize the vertebrae through a posterior approach. The Wiltrom spinal implants aremade of Ti-6Al-4V ELI material which complies with ISO 5832-3 and ASTM F136. Wiltrom Spinal Fixation System is provided nonsterile,and the implants are for single use only. NKB Thoracolumbosacral Pedicle Screw System 2 WILTROM SPINAL FIXATION SYSTEM
3 04719875722318 BC-G29(2.0-3.0mm,30c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
4 04719875722301 BC-G28(2.0-3.0mm,20c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
5 04719873024827 43566550 Polyaxial Reduction Pedicle Screw, Cannulated ø=6.5 L=50 The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link conn The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link connector and associated surgical instruments thatallow the surgeon to build an implant system to fit the patient's anatomical and physiological requirements. The Wiltrom SpinalFixation System is designed to be used to stabilize the vertebrae through a posterior approach. The Wiltrom spinal implants aremade of Ti-6Al-4V ELI material which complies with ISO 5832-3 and ASTM F136. Wiltrom Spinal Fixation System is provided nonsterile,and the implants are for single use only. NKB Thoracolumbosacral Pedicle Screw System 2 Wiltrom Spinal Fixation System
6 04719875722295 BC-G27(2.0-3.0mm,15c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
7 04719875722288 BC-G26(1.0-2.0mm,30c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
8 04719875722271 BC-G25(1.0-2.0mm,20c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
9 04719875722264 BC-G24(1.0-2.0mm,15c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
10 04719875722257 BC-G23(0.5-1.0mm,2c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
11 04719875722240 BC-G22(1.0-2.0mm,2c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
12 04719875722233 BC-G21(2.0-3.0mm,2c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
13 04719875722226 BC-G20(2.0-3.0mm,0.25g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
14 04719875722219 BC-G19 (1.0-2.0mm,1.5g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
15 04719875722202 BC-G18(1.0-2.0mm,1.0g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
16 04719875722196 BC-G17(1.0-2.0mm,0.5g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
17 04719875722189 BC-G16(1.0-2.0mm,0.25g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
18 04719875722172 BC-G15(0.5-1.0mm,1g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
19 04719875722165 BC-G14(0.5-1.0mm,0.5g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
20 04719875722158 BC-G13(0.5-1.0mm,0.25g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
21 04719875722141 BC-G12(0.25-0.5mm,1g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
22 04719875722134 BC-G11(0.25-0.5mm,0.5g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
23 04719875722127 BC-G10(0.25-0.5mm,0.25g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
24 04719875722110 BC-G09(0.5-1.0mm,10c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
25 04719875722103 BC-G08(0.5-1.0mm,7c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
26 04719875722097 BC-G07(1.0-2.0mm,10c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
27 04719875722080 BC-G06(1.0-2.0mm,7c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
28 04719875722073 BC-G05(2.0-3.0mm,10c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
29 04719875722066 BC-G04(2.0-3.0mm,7c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
30 04719875722059 BC-G03(0.5-1.0mm,5c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
31 04719875722042 BC-G02(1.0-2.0mm,5c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
32 04719875722035 BC-G01(2.0-3.0mm,5c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
33 04719875722028 BC-B12 (5x5x10mm,30c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
34 04719875722011 BC-B11 (5x5x10mm,20c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
35 04719875722004 BC-B10 (5x5x20mm,30c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
36 04719875721991 BC-B09 (5x5x20mm,20c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
37 04719875721984 BC-B08 (5x5x20mm,10c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
38 04719875721977 BC-B07(5x5x20mm,7c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
39 04719875721960 BC-B06(5x5x20mm,5c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
40 04719875721953 BC-B05(5x5x10mm,10c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
41 04719875721946 BC-B04(5x5x10mm,7c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
42 04719875721939 BC-B03(5x5x10mm,5c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
43 04719875721922 BC-B02(5x5x10mm,2c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
44 04719873024841 43566560 Polyaxial Reduction Pedicle Screw, Cannulated ø=6.5 L=60 The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link conn The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link connector and associated surgical instruments thatallow the surgeon to build an implant system to fit the patient's anatomical and physiological requirements. The Wiltrom SpinalFixation System is designed to be used to stabilize the vertebrae through a posterior approach. The Wiltrom spinal implants aremade of Ti-6Al-4V ELI material which complies with ISO 5832-3 and ASTM F136. Wiltrom Spinal Fixation System is provided nonsterile,and the implants are for single use only. NKB Thoracolumbosacral Pedicle Screw System 2 Wiltrom Spinal Fixation System
45 04719873024834 43566555 Polyaxial Reduction Pedicle Screw, Cannulated ø=6.5 L=55 The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link conn The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link connector and associated surgical instruments thatallow the surgeon to build an implant system to fit the patient's anatomical and physiological requirements. The Wiltrom SpinalFixation System is designed to be used to stabilize the vertebrae through a posterior approach. The Wiltrom spinal implants aremade of Ti-6Al-4V ELI material which complies with ISO 5832-3 and ASTM F136. Wiltrom Spinal Fixation System is provided nonsterile,and the implants are for single use only. NKB Thoracolumbosacral Pedicle Screw System 2 Wiltrom Spinal Fixation System
46 04719873024810 43566545 Polyaxial Reduction Pedicle Screw, Cannulated ø=6.5 L=45 The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link conn The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link connector and associated surgical instruments thatallow the surgeon to build an implant system to fit the patient's anatomical and physiological requirements. The Wiltrom SpinalFixation System is designed to be used to stabilize the vertebrae through a posterior approach. The Wiltrom spinal implants aremade of Ti-6Al-4V ELI material which complies with ISO 5832-3 and ASTM F136. Wiltrom Spinal Fixation System is provided nonsterile,and the implants are for single use only. NKB Thoracolumbosacral Pedicle Screw System 2 Wiltrom Spinal Fixation System
47 04719873024803 43566540 Polyaxial Reduction Pedicle Screw, Cannulated ø=6.5 L=40 The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link conn The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link connector and associated surgical instruments thatallow the surgeon to build an implant system to fit the patient's anatomical and physiological requirements. The Wiltrom SpinalFixation System is designed to be used to stabilize the vertebrae through a posterior approach. The Wiltrom spinal implants aremade of Ti-6Al-4V ELI material which complies with ISO 5832-3 and ASTM F136. Wiltrom Spinal Fixation System is provided nonsterile,and the implants are for single use only. NKB Thoracolumbosacral Pedicle Screw System 2 Wiltrom Spinal Fixation System
48 04719873024797 43566535 Polyaxial Reduction Pedicle Screw, Cannulated ø=6.5 L=35 The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link conn The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link connector and associated surgical instruments thatallow the surgeon to build an implant system to fit the patient's anatomical and physiological requirements. The Wiltrom SpinalFixation System is designed to be used to stabilize the vertebrae through a posterior approach. The Wiltrom spinal implants aremade of Ti-6Al-4V ELI material which complies with ISO 5832-3 and ASTM F136. Wiltrom Spinal Fixation System is provided nonsterile,and the implants are for single use only. NKB Thoracolumbosacral Pedicle Screw System 2 Wiltrom Spinal Fixation System
49 04719873024780 43566530 Polyaxial Reduction Pedicle Screw, Cannulated ø=6.5 L=30 The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link conn The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link connector and associated surgical instruments thatallow the surgeon to build an implant system to fit the patient's anatomical and physiological requirements. The Wiltrom SpinalFixation System is designed to be used to stabilize the vertebrae through a posterior approach. The Wiltrom spinal implants aremade of Ti-6Al-4V ELI material which complies with ISO 5832-3 and ASTM F136. Wiltrom Spinal Fixation System is provided nonsterile,and the implants are for single use only. NKB Thoracolumbosacral Pedicle Screw System 2 Wiltrom Spinal Fixation System
50 04719873024773 43566055 Polyaxial Reduction Pedicle Screw, Cannulated ø=6.0 L=55 The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link conn The Wiltrom Spinal Fixation System is comprised of screws, rods, cross-link connector and associated surgical instruments thatallow the surgeon to build an implant system to fit the patient's anatomical and physiological requirements. The Wiltrom SpinalFixation System is designed to be used to stabilize the vertebrae through a posterior approach. The Wiltrom spinal implants aremade of Ti-6Al-4V ELI material which complies with ISO 5832-3 and ASTM F136. Wiltrom Spinal Fixation System is provided nonsterile,and the implants are for single use only. NKB Thoracolumbosacral Pedicle Screw System 2 Wiltrom Spinal Fixation System
Other products with the same Product Code "MQV"
No Primary DI Version or Model Catalog Number Device Description Brand Name Organization Name
1 H132001109132151 00-1109-132-15 00-1109-132-15 Synthetic Bone Resorbable GraftCone 12 TRIOSITE BIOMATLANTE
2 H132001109115021 00-1109-115-02 00-1109-115-02 Synthétic Bone Resorbable GraftGranules 2-4mm 16cc TRIOSITE BIOMATLANTE
3 H132001109115011 00-1109-115-01 00-1109-115-01 Synthetic bone Resorbable GraftGranules 2-3mm TRIOSITE BIOMATLANTE
4 H132001109114021 00-1109-114-02 00-1109-114-02 Synthetic Bone Resorbable GraftStick 5x5x20mm TRIOSITE BIOMATLANTE
5 H132001109113011 00-1109-113-01 00-1109-113-01 Synthetic Bone Resorbable GraftStick 5x5x10mm TRIOSITE BIOMATLANTE
6 H132001109085151 00-1109-085-15 00-1109-085-15 Synthetic Bone Resorbable GraftCone TRIOSITE BIOMATLANTE
7 H132001109006121 00-1109-006-12 00-1109-006-12 Synthetic Bone Resorbable GraftWedge 12mm TRIOSITE BIOMATLANTE
8 H132001109005251 00-1109-005-25 00-1109-005-25 Synthetic Bone Resorbable GraftDisc TRIOSITE BIOMATLANTE
9 H132001109005101 00-1109-005-10 00-1109-005-10 Synthetic Bone Resorbable GraftWedge 10mm TRIOSITE BIOMATLANTE
10 H132001109005031 00-1109-005-03 00-1109-005-03 Synthetic Bone Resorbable GraftGranules 2-3mm 5cc TRIOSITE BIOMATLANTE
11 H132001109000481 00-1109-000-48 00-1109-000-48 Synthetic Bone Resorbable GraftWedge 8mm TRIOSITE BIOMATLANTE
12 H132001109000361 00-1109-000-36 00-1109-000-36 Synthetic Bone Resorbable GraftWedge 6mm TRIOSITE BIOMATLANTE
13 H132000060130001 00-0060-130-00 00-0060-130-00 Synthetic Bone Resorbable Graft Granules 0.5-1mm TRIOSITE BIOMATLANTE
14 H131001109114011 00-1109-114-01 00-1109-114-01 Synthetic Bone Resorbable GraftStick 5x5x20mm TRIOSITE BIOMATLANTE
15 H131001109113021 00-1109-113-02 00-1109-113-02 synthetic Bone Resorbable GraftStick 5x5x10mm TRIOSITE BIOMATLANTE
16 04250971422097 T671CB15-3-1 6.1/7.1CB1.5 Synthacer®/Syntricer® 300 Ceraball®, mixture of HA and TCP, diameter 1.5 mm, 3 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
17 04250971422080 T671CB15-2-1 6.1/7.1CB1.5 Synthacer®/Syntricer® 300 Ceraball®, mixture of HA and TCP, diameter 1.5 mm, 2 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
18 04250971422073 T671CB15-1-1 6.1/7.1CB1.5 Synthacer®/Syntricer® 300 Ceraball®, mixture of HA and TCP, diameter 1.5 mm, 1 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
19 04250971422066 T672CB03-5-1 6.2/7.2CB03 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 3 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
20 04250971422059 T672CB03-2-1 6.2/7.2CB03 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 3 mm, 2 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
21 04250971422042 T672CB03-1-1 6.2/7.2CB03 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 3 mm, 1 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
22 04250971422035 T672CB0406-30-1 6.2/7.2CB0406 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diamete Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diameters 4 mm and 6 mm, 30 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
23 04250971422028 T672CB0406-20-1 6.2/7.2CB0406 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diamete Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diameters 4 mm and 6 mm, 20 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
24 04250971422011 T672CB0406-10-1 6.2/7.2CB0406 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diamete Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diameters 4 mm and 6 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
25 04250971422004 T672CB0406-5-1 6.2/7.2CB0406 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diamete Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diameters 4 mm and 6 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
26 04250971421991 T672CB06-10-1 6.2/7.2CB06 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 6 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
27 04250971421984 T672CB06-5-1 6.2/7.2CB06 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 6 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
28 04250971421977 T672CB04-10-1 6.2/7.2CB04 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 4 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
29 04250971421960 T672G03-30-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 30 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
30 04250971421953 T672G03-20-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 20 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
31 04250971421946 T672G03-15-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 15 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
32 04250971421939 T672G03-10-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
33 04250971421922 T672G03-5-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
34 04250971421915 T672G03-2-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 2 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
35 04250971421908 T672G03-1-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 1 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
36 04250971421892 T672G02-30-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 30 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
37 04250971421885 T672G02-20-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 20 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
38 04250971421878 T672G02-15-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 15 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
39 04250971421861 T672G02-10-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
40 04250971421854 T672G02-5-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
41 04250971421847 T672G02-2-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 2 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
42 04250971421830 T672G02-1-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 1 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
43 04250971421823 T672G01-30-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 30 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
44 04250971421816 T672G01-20-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 20 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
45 04250971421809 T672G01-15-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 15 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
46 04250971421793 T672G01-10-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
47 04250971421786 T672G01-5-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
48 04250971421779 T672G01-2-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 2 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
49 04250971421762 T672G01-1-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 1 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
50 04250971421755 T71CB15-3-1 7.1CB1.5 Syntricer® 300 Ceraball®, TCP, diameter 1.5 mm, 3 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT